Hoyer L W, Trabold N C
J Clin Invest. 1970 Jan;49(1):87-95. doi: 10.1172/JCI106226.
The importance of antigen site density has been studied by means of a model passive hemagglutination system using human red cells coupled with sulfanilic acid groups. Relative site numbers were estimated from the covalent linkage of sulfanilic acid-(35)S to red cell membrane protein and the effective antigen site number was determined with (125)I-labeled rabbit IgG antisulfanilic acid. Cells which had fewer than 20,000 antigen sites per cell were not agglutinated. As greater numbers of sulfanilic groups were coupled to the red cells, the agglutination titers increased to maximum values with red fanilic groups were coupled to the red cells, the agglutination titers of purified IgM antibody were 10-20 times greater than IgG antibody when preparations with the same protein concentration were compared, but this difference was not noted when IgG antibody was measured by antiglobulin reactions. These findings emphasize the need to consider differences in antigen site density when comparing blood group systems. They are consistent with the hypothesis that those blood group antigens which have a very low site number will not be detected by IgG antibodies in saline hemagglutination determinations.
利用一种模型被动血凝系统,通过将人红细胞与磺胺酸基团偶联,对抗原位点密度的重要性进行了研究。从磺胺酸 -(35)S与红细胞膜蛋白的共价连接来估算相对位点数量,并用(125)I标记的兔IgG抗磺胺酸来确定有效抗原位点数量。每个细胞少于20,000个抗原位点的细胞不会发生凝集。随着越来越多的磺胺基团与红细胞偶联,凝集效价增加至最大值。当比较相同蛋白质浓度的制剂时,纯化的IgM抗体的凝集效价是IgG抗体的10 - 20倍,但在用抗球蛋白反应检测IgG抗体时未发现这种差异。这些发现强调了在比较血型系统时考虑抗原位点密度差异的必要性。它们与以下假设一致,即在盐水血凝测定中,那些位点数量非常低的血型抗原不会被IgG抗体检测到。